FDA has denied the final two pending OTC sunscreen ingredient applications and offered perspective on why it is not approving the proposals after Congress passed 2014 legislation to facilitate making more of the ingredients available.
In separate proposed orders to be published in the Feb. 25 Federal Register, FDA rejected [L'Oreal USA Inc.]’s time and extent application for ecamsule and Merck & Co. Inc
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?